Article Text
Abstract
Myotonic dystrophy type 1 (DM1), the most common muscular dystrophy in adults, is an autosomal dominant disorder with a wide phenotypic spectrum ranging from oligosymptomatic forms to a life-threatening, multisystem disease. People with DM1 overall have a reduced life expectancy, mainly due to respiratory or cardiac causes. There is no cure but prompt, appropriate symptom management is essential to limit disease-related complications. We present a case of DM1, unrecognised when the patient presented with recurrent type 2 respiratory failure, and initially misdiagnosed as Guillain-Barré syndrome. This misdiagnosis subsequently led to unnecessary investigation and treatment before further detailed neurological examination and collateral family history gave the diagnosis. This case highlights the importance of considering a chronic neuromuscular disorder in patients presenting with acute respiratory failure and an unusual pattern of weakness.
- Myotonic dystrophy
Statistics from Altmetric.com
Footnotes
Contributors CK, AT and VA wrote the manuscript, CK, VA and BM reviewed, edited and approved the final version of the manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Consent obtained directly from patient(s).
Provenance and peer review Not commissioned. Externally peer reviewed by Jon Walters, Swansea, UK.
Linked Articles
- Editors’ commentary
Read the full text or download the PDF:
Other content recommended for you
- Neuromuscular junction disorders: mimics and chameleons
- Muscle diseases: mimics and chameleons
- Weakness on the intensive care unit
- Muscle disease
- Acute respiratory failure in a middle aged woman
- The myotonic dystrophies: diagnosis and management
- Neuromuscular disease and respiratory failure
- Weakness in the intensive care unit
- Respiratory involvement in inherited primary muscle conditions
- Mimics and chameleons in Guillain–Barré and Miller Fisher syndromes